1. 409 Serum Ca125 in patients with endometrial cancer. (18th September 2019) Authors: Hashiguchi, Y; Yamauchi, M; Kasai, M; Fukuda, T; Ichimura, T; Yasui, T; Sumi, T Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 3 Page Start: A170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 492PA multicenter phase II trial to evaluate the efficacy of mFOLFOX6+cetuximab as induction chemotherapy to achieve R0 surgical resection for advanced colorectal liver metastases (NEXTO trial). (23rd October 2018) Authors: Nishioka, Y; Hasegawa, K; Saiura, A; Oba, M; Yamamoto, J; Nomura, Y; Takayama, T; Hashiguchi, Y; Shibasaki, M; Sakamoto, H; Yamagata, S; Aoyanagi, N; Kaneko, H; Koyama, H; Miyagawa, S; Mise, Y; Shinozaki, E; Yoshida, S; Nozawa, H; Kokudo, N Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Predictive immunohistochemical features for tumour response to chemoradiotherapy in rectal cancer. Issue 2 (5th February 2020) Authors: Shinto, E; Omata, J; Sikina, A; Sekizawa, A; Kajiwara, Y; Hayashi, K; Hashiguchi, Y; Hase, K; Ueno, H Journal: BJS open Issue: Volume 4:Issue 2(2020) Page Start: 301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗